Effects of hypoxia and hyperoxia on the differential expression of VEGF-A isoforms and receptors in Idiopathic Pulmonary Fibrosis (IPF)

Respir Res. 2018 Jan 15;19(1):9. doi: 10.1186/s12931-017-0711-x.

Abstract

Dysregulation of VEGF-A bioavailability has been implicated in the development of lung injury/fibrosis, exemplified by Idiopathic Pulmonary Fibrosis (IPF). VEGF-A is a target of the hypoxic response via its translational regulation by HIF-1α. The role of hypoxia and hyperoxia in the development and progression of IPF has not been explored. In normal lung (NF) and IPF-derived fibroblasts (FF) VEGF-Axxxa protein expression was upregulated by hypoxia, mediated through activation of VEGF-Axxxa gene transcription. VEGF-A receptors and co-receptors were differentially expressed by hypoxia and hyperoxia. Our data supports a potential role for hypoxia, hyperoxia and VEGF-Axxxa isoforms as drivers of fibrogenesis.

Keywords: Hypoxia; Idiopathic pulmonary fibrosis; Interstitial lung disease; Vascular endothelial growth factor.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aerobiosis / physiology
  • Cell Hypoxia / physiology
  • Cells, Cultured
  • Fibroblasts / metabolism
  • Fibroblasts / pathology
  • Gene Expression
  • Humans
  • Idiopathic Pulmonary Fibrosis / metabolism*
  • Idiopathic Pulmonary Fibrosis / pathology
  • Lung / metabolism*
  • Lung / pathology
  • Protein Isoforms / biosynthesis
  • Protein Isoforms / genetics
  • Receptors, Vascular Endothelial Growth Factor / biosynthesis*
  • Receptors, Vascular Endothelial Growth Factor / genetics
  • Vascular Endothelial Growth Factor A / biosynthesis*
  • Vascular Endothelial Growth Factor A / genetics

Substances

  • Protein Isoforms
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Receptors, Vascular Endothelial Growth Factor